DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $96.03 million. The enterprise value is $43.54 million.

Market Cap	96.03M
Enterprise Value	43.54M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

DMAC has 37.96 million shares outstanding. The number of shares has increased by 23.16% in one year.

Shares Outstanding	37.96M
Shares Change (YoY)	+23.16%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	26.65%
Owned by Institutions (%)	22.01%
Float	23.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.88
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.27, with a Debt / Equity ratio of 0.01.

Current Ratio	19.27
Quick Ratio	19.12
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.90% and return on invested capital (ROIC) is -41.33%.

Return on Equity (ROE)	-39.90%
Return on Assets (ROA)	-37.70%
Return on Capital (ROIC)	-41.33%
Revenue Per Employee	n/a
Profits Per Employee	-$1.07M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $43,000 in taxes.

Income Tax	43,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.36% in the last 52 weeks. The beta is 1.74, so DMAC's price volatility has been higher than the market average.

Beta (1Y)	1.74
52-Week Price Change	+65.36%
50-Day Moving Average	2.79
200-Day Moving Average	2.81
Relative Strength Index (RSI)	45.67
Average Volume (30 Days)	39,840

Short Selling Information

The latest short interest is 175,427, so 0.46% of the outstanding shares have been sold short.

Short Interest	175,427
Short Previous Month	202,168
Short % of Shares Out	0.46%
Short % of Float	0.74%
Short Ratio (days to cover)	3.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.27M
Pretax Income	-19.26M
Net Income	-19.30M
EBITDA	-19.16M
EBIT	-19.26M
Earnings Per Share (EPS)	-$0.60

Full Income Statement

Balance Sheet

The company has $52.90 million in cash and $400,000 in debt, giving a net cash position of $52.50 million or $1.38 per share.

Cash & Cash Equivalents	52.90M
Total Debt	400,000
Net Cash	52.50M
Net Cash Per Share	$1.38
Equity / Book Value	51.06M
Book Value Per Share	1.35
Working Capital	50.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.73 million and capital expenditures -$24,000, giving a free cash flow of -$18.75 million.

Operating Cash Flow	-18.73M
Capital Expenditures	-24,000
Free Cash Flow	-18.75M
FCF Per Share	-$0.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.16%
Shareholder Yield	-23.16%
Earnings Yield	-20.10%
FCF Yield	-19.53%

Analyst Forecast

The average price target for DMAC is $7.00, which is 176.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	176.68%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	3